|drug3527||Sampling (EDTA blood, pharyngeal and nose swabs, bronchoalveolar lavage ,urine) Wiki||1.00|
|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
The 2019-2020 coronavirus pandemic has had far-reaching consequences beyond the spread of the disease. Quarantine measures during a public health pandemic can be particularly detrimental to urban poor families and affect the dietary diversity and food security. This can disproportionately affect young children aged 6 and below, and severely impact those <2 years. Sudden unemployment may result in an unexpected reduction in income that will place pressure on daily budgets for food. Children of families may not have access to foods of adequate diversity that will enable them to meet their macro and micronutrient requirements for growth and development, especially during the Movement Control Order (MCO). The study plans to monitor and evaluate dietary diversity in young children's food intake after the MCO and use the collected information to direct targeted food aid to address observed macro- and micronutrient deficiencies among the urban vulnerable group.
Description: Number of food groups in 24 hoursMeasure: Minimal Dietary Diversity (MDD) of more than 5 food groups in 24 hours Time: 24 hours
Description: Height increase in centimetresMeasure: Height Time: 4 months
Description: Weight increase in kilogramMeasure: Weight Time: 4 months
Description: Number of meal frequenciesMeasure: Meal frequencies in past 24 hours Time: 24 hours
Description: Change in gram/LMeasure: Blood hemoglobin in children at the start of study and 4 months later Time: 4 months
Description: Change in microgram/LMeasure: Serum ferritin in children at the start of study and 4 months later Time: 4 months
Description: Number of typesMeasure: Consumption of sugar and processed foods Time: 1 month
Description: Types of food groupsMeasure: Food Aids received Time: 1 month
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports